Sanofi(SNY)
Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris, France. Originally, the corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company is a component of the Euro Stoxx 50 stock market index.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
Mock data
Subscribe for the real data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name | Drug Name | Approved | Patent Expires | Indication |
|---|---|---|---|---|
| Accurbron | Theophylline | 1985-11-22 | ||
| Acomplia | Rimonabant | 2006-06-19 | ||
| Acthar | Corticotropin | 1982-01-01 | 2041 | |
| Adlyxin | Lixisenatide | 2016-07-27 | ||
| Admelog | Insulin lispro | 2017-12-11 | ||
| Aldurazyme | Laronidase | 2003-06-09 | ||
| Allegr | Fexofenadine, Pseudoephedrine | 2011-01-24 | 2024-2027 | |
| Allegra | Fexofenadine | 1996-07-25 | 2030 |
1
2
3
4
5
6
...
19
>
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Indication |
|---|---|---|---|---|---|
1
2
3
4
5
6
...
34
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use